Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ETRA

Updated 10/6/2026, 2:28 PM ET.

ETRA

Electra Therapeutics, Inc.

Buy$19,999,995

GORDON CARL L

Director, 10% owner

1,333,333 shat $15.00Filed Sep 23, 5:35 PM ETFiling
ETRA

Electra Therapeutics, Inc.

Buy$19,999,995

ORBIMED ADVISORS LLC

Director, 10% owner

and 2 others

1,333,333 shat $15.00Filed Sep 23, 5:29 PM ETFiling

Read from public SEC filings. Not financial advice.